Schulz Fran 4
4 · Senti Biosciences, Inc. · Filed Dec 10, 2024
Insider Transaction Report
Form 4
Schulz Fran
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-12-09+12,500→ 12,500 totalExercise: $6.52Exp: 2034-12-08→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in 36 substantially equal monthly installments over three years from December 9, 2024, subject to the reporting person's continued service through the applicable vesting date.